Dilaudid 2mg/ml Pf Inj, 1ml

Manufacturer FRESENIUS KABI USA Active Ingredient Hydromorphone Injection(hye droe MOR fone) Pronunciation hye droe MOR fone
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated.Make sure you have the right drug; there is more than one strength. A lower strength may not ease pain well enough. A higher strength could lead to accidental overdose and death.Certain strengths of this drug may only be used by people who have been taking drugs like this drug and are used to their effects. The use of these strengths by people who have not been taking drugs like this drug may cause very bad and sometimes deadly breathing problems. Talk with the doctor. @ COMMON USES: It is used to manage pain when non- opioid pain drugs do not treat your pain well enough or you cannot take them.
đŸˇī¸
Drug Class
Opioid analgesic
đŸ§Ŧ
Pharmacologic Class
Opioid agonist
🤰
Pregnancy Category
Not available
✅
FDA Approved
Jan 1926
âš–ī¸
DEA Schedule
Schedule II

Overview

â„šī¸

What is this medicine?

Hydromorphone is a strong pain medicine, also known as an opioid. It works in your brain and nervous system to change how your body feels and responds to pain. It is given by injection (shot) for severe pain.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. Take this medication exactly as directed, and be sure to follow all instructions provided. This medication is administered via injection into a muscle, vein, or the fatty layer under the skin.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.

If you miss a dose, contact your doctor immediately to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause drowsiness and dizziness.
  • Do not drink alcohol while taking this medication, as it can increase the risk of serious side effects like severe drowsiness and breathing problems.
  • Do not take other medications that make you sleepy (like benzodiazepines, sleeping pills, or other pain medications) without discussing with your doctor, as this can lead to dangerous breathing problems.
  • To prevent constipation, drink plenty of fluids, eat fiber-rich foods, and discuss a bowel regimen with your healthcare provider.
  • Keep this medication out of reach of children and pets, as accidental ingestion can be fatal.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: IV: 0.2-1 mg every 2-3 hours as needed; IM/SC: 1-2 mg every 4-6 hours as needed
Dose Range: 0.2 - 4 mg

Condition-Specific Dosing:

acutePain_IV: 0.2-1 mg every 2-3 hours as needed, titrated to effect
acutePain_IM_SC: 1-2 mg every 4-6 hours as needed, titrated to effect
chronicPain_IV_continuousInfusion: Initial 0.5-1 mg/hr, titrated based on patient response and prior opioid use
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (use with extreme caution, if at all, due to risk of respiratory depression)
Infant: Not established (use with extreme caution, if at all)
Child: IV/IM/SC: 0.015 mg/kg/dose every 4-6 hours as needed (max 0.1 mg/kg/dose or 2 mg/dose, whichever is less). Use with extreme caution.
Adolescent: IV/IM/SC: 0.015 mg/kg/dose every 4-6 hours as needed (max 0.1 mg/kg/dose or 2 mg/dose, whichever is less). Consider adult dosing for older adolescents.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment, but monitor closely for increased effects.
Moderate: Reduce initial dose by 25-50% and extend dosing interval. Monitor closely.
Severe: Reduce initial dose by 50-75% and extend dosing interval significantly. Avoid if possible. Monitor closely.
Dialysis: Hydromorphone is not significantly removed by dialysis. Administer after dialysis. Reduce dose and extend interval.

Hepatic Impairment:

Mild: No specific dose adjustment, but monitor closely.
Moderate: Reduce initial dose by 25-50% and monitor closely.
Severe: Reduce initial dose by 50-75% and monitor closely. Avoid if possible.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Hydromorphone is a full opioid agonist that binds to mu-opioid receptors in the central nervous system (CNS), peripheral tissues, and gastrointestinal tract. Its primary therapeutic effects (analgesia, sedation) are mediated through activation of mu-opioid receptors. It also produces respiratory depression, miosis, euphoria, and physical dependence.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: IV: 5-10 minutes; IM: 15-30 minutes; SC: 30-90 minutes
FoodEffect: Not applicable for injection

Distribution:

Vd: 3-4 L/kg
ProteinBinding: 8-19%
CnssPenetration: Yes

Elimination:

HalfLife: 2-3 hours
Clearance: 1.9 L/min
ExcretionRoute: Renal (primarily as H3G)
Unchanged: <10%
âąī¸

Pharmacodynamics

OnsetOfAction: IV: 5 minutes; IM: 15-30 minutes; SC: 30 minutes
PeakEffect: IV: 10-20 minutes; IM: 30-60 minutes; SC: 60-90 minutes
DurationOfAction: IV/IM/SC: 3-4 hours

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 3A4 INTERACTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; and ALCOHOL INTERACTION.
âš ī¸

Side Effects

Important Side Effects to Report to Your Doctor Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or passing out
Feeling confused
Severe constipation or stomach pain, which may be signs of a severe bowel problem
Abnormal heartbeat, including fast, slow, or irregular rhythms
Breathing difficulties, including:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Hallucinations (seeing or hearing things that are not there)
Mood changes
Seizures
Shakiness
Trouble passing urine
Inability to control eye movements
Trouble controlling body movements
Changes in eyesight
Chest pain or pressure
Changes in balance
Memory problems or loss
Thoughts of hurting yourself or suicide
Swelling in the arms or legs

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk of developing serotonin syndrome, a severe and potentially deadly condition. Seek medical attention immediately if you experience any of the following symptoms:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Throwing up
Severe headache

Long-Term Use and Hormonal Changes

Long-term use of opioid medications like this one may lead to lower sex hormone levels. If you experience any of the following symptoms, contact your doctor:

Decreased interest in sex
Fertility problems
No menstrual period
Ejaculation problems

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following possible side effects:

Constipation
Diarrhea
Stomach pain
Upset stomach
Throwing up
Decreased appetite
Dizziness
Sleepiness
Tiredness
Weakness
Dry mouth
Flushing
Excessive sweating
Headache
Itching
* Trouble sleeping

If any of these side effects bother you or do not go away, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow or shallow breathing (less than 10 breaths per minute)
  • Extreme drowsiness or difficulty waking up
  • Bluish lips or fingernails
  • Severe dizziness or lightheadedness
  • Confusion or disorientation
  • Severe constipation or abdominal pain
  • Signs of an allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
If you have taken specific medications for depression or Parkinson's disease within the last 14 days, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
If you are currently taking any of the following medications: buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine

Please note that this is not an exhaustive list of all potential interactions. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to ensure safe use. Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require you to be alert. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.

Dosage and Administration
Do not exceed the dose prescribed by your doctor. Taking more than the recommended dose, or taking it more frequently or for a longer period than directed, may increase the risk of severe side effects.

Interactions with Other Medications
Before taking this medication with other strong pain medications or using a pain patch, consult your doctor. If you experience worsening pain, increased sensitivity to pain, or new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Long-Term Use and Monitoring
If you are taking this medication for an extended period, your doctor may recommend regular blood tests to monitor your condition.

Allergies and Sensitivities
If you are allergic to sulfites, discuss this with your doctor, as some products may contain sulfites.

Alcohol Interactions
Do not consume alcohol or products containing alcohol while taking this medication, as this may lead to unsafe and potentially life-threatening effects.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, requiring higher doses to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.

Dependence and Withdrawal
Regular use of opioid medications like this one may cause dependence. If you need to reduce the dose or stop taking this medication, consult your doctor to avoid withdrawal or other severe problems. Follow your doctor's instructions carefully and report any increased pain, mood changes, suicidal thoughts, or other adverse effects.

Seizure Risk
This medication may increase the risk of seizures, particularly in individuals with a history of seizures. Discuss your risk with your doctor.

Adrenal Gland Problems
Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. If you experience extreme fatigue, weakness, fainting, severe dizziness, nausea, vomiting, or decreased appetite, contact your doctor immediately.

Special Precautions for Older Adults
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding
If you are breastfeeding, inform your doctor, as this medication passes into breast milk and may harm your baby. Seek medical help immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
🆘

Overdose Information

Overdose Symptoms:

  • Pinpoint pupils
  • Slowed or stopped breathing
  • Extreme drowsiness or unresponsiveness
  • Limp muscles
  • Cold, clammy skin
  • Bluish discoloration of lips and fingernails
  • Loss of consciousness
  • Coma

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Call 1-800-222-1222 (Poison Control Center) for additional guidance.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI therapy (risk of serotonin syndrome, severe respiratory depression, coma, death)
🔴

Major Interactions

  • Benzodiazepines and other CNS depressants (e.g., other opioids, sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, alcohol): Increased risk of profound sedation, respiratory depression, coma, and death.
  • Mixed opioid agonist/antagonists (e.g., pentazocine, nalbuphine, butorphanol): May reduce the analgesic effect of hydromorphone and/or precipitate withdrawal symptoms.
  • Partial opioid agonists (e.g., buprenorphine): May reduce the analgesic effect of hydromorphone and/or precipitate withdrawal symptoms.
🟡

Moderate Interactions

  • Anticholinergic drugs (e.g., tricyclic antidepressants, antihistamines, antipsychotics, antiemetics): Increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome (especially with MAOIs, but also with other serotonergic agents).
đŸŸĸ

Minor Interactions

  • Diuretics: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pain assessment (intensity, location, quality)

Rationale: To establish baseline pain level and guide initial dosing.

Timing: Prior to first dose

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk for respiratory depression.

Timing: Prior to first dose

Level of consciousness/sedation

Rationale: To assess baseline mental status and identify risk for excessive sedation.

Timing: Prior to first dose

Vital signs (heart rate, blood pressure)

Rationale: To establish baseline cardiovascular status.

Timing: Prior to first dose

Renal and hepatic function tests (e.g., BUN, creatinine, LFTs)

Rationale: To identify potential impairment that may require dose adjustment.

Timing: Prior to initiation, especially in patients with known or suspected impairment

📊

Routine Monitoring

Pain assessment

Frequency: Every 2-3 hours initially, then as needed based on patient response and dosing interval

Target: Acceptable pain level (e.g., 0-3/10 on a numeric scale)

Action Threshold: Uncontrolled pain (e.g., >4/10) or inadequate relief; consider dose adjustment or alternative therapy.

Respiratory rate and depth

Frequency: Every 15-30 minutes for 1-2 hours after IV dose, then every 1-4 hours or as clinically indicated

Target: 12-20 breaths/minute (adults), regular rhythm

Action Threshold: <10 breaths/minute (adults), shallow breathing, or signs of respiratory distress; administer naloxone, provide respiratory support.

Level of consciousness/sedation (e.g., Pasero Opioid-Induced Sedation Scale)

Frequency: Every 15-30 minutes for 1-2 hours after IV dose, then every 1-4 hours or as clinically indicated

Target: Awake and alert or mildly drowsy, easily aroused

Action Threshold: Difficult to arouse, somnolent, or unarousable; administer naloxone, reduce dose, or hold next dose.

Bowel function (e.g., frequency of bowel movements, presence of constipation)

Frequency: Daily

Target: Regular bowel movements (at least every 2-3 days)

Action Threshold: Constipation (no bowel movement for >3 days); initiate bowel regimen, consider opioid-induced constipation (OIC) specific agents.

đŸ‘ī¸

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing, cyanosis)
  • Excessive sedation/somnolence
  • Nausea and vomiting
  • Constipation
  • Pruritus (itching)
  • Dizziness/lightheadedness
  • Hypotension
  • Urinary retention

Special Patient Groups

🤰

Pregnancy

Use during pregnancy is generally not recommended due to potential for fetal harm, including neonatal opioid withdrawal syndrome (NOWS). Prolonged use during pregnancy can lead to physical dependence in the fetus, resulting in NOWS after birth. NOWS can be life-threatening if not recognized and treated.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for congenital malformations with opioid exposure. Risk generally considered low but not zero.
Second Trimester: Risk of fetal growth restriction and other adverse outcomes with prolonged use.
Third Trimester: High risk of neonatal opioid withdrawal syndrome (NOWS) if used chronically. Risk of respiratory depression in the neonate if used close to delivery.
🤱

Lactation

Hydromorphone is excreted into breast milk. While levels are generally low, there is a risk of sedation, respiratory depression, and poor feeding in the breastfed infant. Monitor infants closely for signs of sedation, difficulty breathing, or increased drowsiness. Use with caution, or consider alternative analgesics if possible. If used, use the lowest effective dose for the shortest duration.

Infant Risk: Moderate risk (L3) - potential for adverse effects on the infant; monitor closely.
đŸ‘ļ

Pediatric Use

Use with extreme caution due to increased sensitivity to respiratory depression. Dosing must be carefully calculated based on weight and titrated to effect. Not recommended for neonates or infants due to lack of established safety and efficacy.

👴

Geriatric Use

Start with lower doses and titrate slowly due to increased sensitivity to opioids, decreased renal and hepatic function, and increased risk of respiratory depression, sedation, and falls. Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Hydromorphone is significantly more potent than morphine (approximately 5-7 times). Always verify dose calculations carefully to avoid overdose.
  • Rapid IV administration can lead to severe respiratory depression, hypotension, and circulatory collapse. Administer IV doses slowly over at least 2-3 minutes.
  • The metabolite hydromorphone-3-glucuronide (H3G) can accumulate in renal impairment, potentially causing neuroexcitatory symptoms (e.g., myoclonus, hyperalgesia, delirium). Monitor patients with renal dysfunction closely.
  • Tolerance and physical dependence can develop with prolonged use. Do not abruptly discontinue in physically dependent patients; taper gradually to prevent withdrawal symptoms.
  • Naloxone should be readily available for reversal of opioid-induced respiratory depression.
  • Consider a bowel regimen (stool softener + stimulant laxative) proactively to prevent opioid-induced constipation.
🔄

Alternative Therapies

  • Other opioid analgesics (e.g., morphine, fentanyl, oxycodone, hydrocodone)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen)
  • Regional anesthesia/nerve blocks
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, tricyclic antidepressants for neuropathic pain)
  • Non-pharmacological pain management (e.g., physical therapy, heat/cold therapy, massage, acupuncture)
💰

Cost & Coverage

Average Cost: Highly variable, typically $5-$50 per 1ml vial (2mg/ml) per 1ml vial
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (for brand, if applicable)
📚

General Drug Facts

It is essential to monitor your symptoms and health problems while taking this medication. If you notice no improvement or a worsening of your condition, contact your doctor promptly.

To ensure safe use, never share your medication with others, and do not take anyone else's medication. Store all medications in a secure location, out of reach of children and pets. Properly dispose of unused or expired medications by throwing them away. However, do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. If you are unsure about the best method for disposing of medications, consult with your pharmacist, who can also inform you about potential drug take-back programs in your area.

This medication is accompanied by a Medication Guide, which provides crucial information for patients. Read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be used as part of the treatment. Consult with your doctor or pharmacist about obtaining and using naloxone. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about what was taken, the amount, and the time it happened.

In case of a suspected overdose, contact your local poison control center or seek medical care immediately. When seeking help, be ready to provide details about the medication, including the dose taken and the time of the incident.